Integrum appoints Supply Chain Manager
Mölndal, Sweden – May 29, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has appointed Katarina Oderland as new Supply Chain Manager. Katarina Oderland will join the company on 14 August 2023 and will be part of the management team.
Katarina Oderland has a long experience within supply chain and customer service management, as well as accounting, most recently working at Essity and Abigo Medical, and previously also with Ericsson.
“We are happy to welcome Katarina Oderland to Integrum. Supply chain, logistics and procurement management are increasingly important in our ongoing international expansion and Katarina Oderlands knowledge and experience in the area will be a great contribution to our management team,” says Rickard Brånemark, CEO of Integrum.
For more information please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: rickard.branemark@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser.
ABOUT INTEGRUM
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™ System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.